GB201316857D0 - Composition for the oral delivery of compounds - Google Patents

Composition for the oral delivery of compounds

Info

Publication number
GB201316857D0
GB201316857D0 GB201316857A GB201316857A GB201316857D0 GB 201316857 D0 GB201316857 D0 GB 201316857D0 GB 201316857 A GB201316857 A GB 201316857A GB 201316857 A GB201316857 A GB 201316857A GB 201316857 D0 GB201316857 D0 GB 201316857D0
Authority
GB
United Kingdom
Prior art keywords
compounds
composition
oral delivery
oral
delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB201316857A
Original Assignee
Buckley Howard
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Buckley Howard filed Critical Buckley Howard
Priority to GB201316857A priority Critical patent/GB201316857D0/en
Publication of GB201316857D0 publication Critical patent/GB201316857D0/en
Application status is Ceased legal-status Critical

Links

GB201316857A 2013-09-23 2013-09-23 Composition for the oral delivery of compounds Ceased GB201316857D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB201316857A GB201316857D0 (en) 2013-09-23 2013-09-23 Composition for the oral delivery of compounds

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB201316857A GB201316857D0 (en) 2013-09-23 2013-09-23 Composition for the oral delivery of compounds
GB201407847A GB2518475A (en) 2013-09-23 2014-05-02 Composition for the oral delivery of compounds
PCT/GB2014/052870 WO2015040422A1 (en) 2013-09-23 2014-09-22 Composition for the oral delivery of compounds

Publications (1)

Publication Number Publication Date
GB201316857D0 true GB201316857D0 (en) 2013-11-06

Family

ID=49553259

Family Applications (2)

Application Number Title Priority Date Filing Date
GB201316857A Ceased GB201316857D0 (en) 2013-09-23 2013-09-23 Composition for the oral delivery of compounds
GB201407847A Withdrawn GB2518475A (en) 2013-09-23 2014-05-02 Composition for the oral delivery of compounds

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB201407847A Withdrawn GB2518475A (en) 2013-09-23 2014-05-02 Composition for the oral delivery of compounds

Country Status (2)

Country Link
GB (2) GB201316857D0 (en)
WO (1) WO2015040422A1 (en)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5085865A (en) * 1989-04-12 1992-02-04 Warner-Lambert Company Sustained release pharmaceutical preparations containing an analgesic and a decongestant
ES2051658T3 (en) * 1992-08-06 1998-06-16 Gergely Gerhard Effervescent tablets easy to administer.
US5558879A (en) * 1995-04-28 1996-09-24 Andrx Pharmaceuticals, Inc. Controlled release formulation for water soluble drugs in which a passageway is formed in situ
US6210710B1 (en) * 1997-04-28 2001-04-03 Hercules Incorporated Sustained release polymer blend for pharmaceutical applications
FR2787715B1 (en) * 1998-12-23 2002-05-10 Synthelabo A pharmaceutical composition comprising a hypnotic compound or a pharmaceutically acceptable salt thereof
DE19931667A1 (en) * 1999-07-08 2001-01-11 Basf Ag Flexible, water-soluble or water-dispersible coating agent, binder or film former for pharmaceutical formulations, comprises new or known vinyl ester-polyether graft copolymer,
DE10207427A1 (en) * 2002-02-21 2003-09-04 Basf Ag Schnelllöslicher film coating based on polyvinyl alcohol-polyether graft copolymers in combination with hydroxyl, amide, or Esterfunktionen containing components
US7157100B2 (en) * 2002-06-04 2007-01-02 J.B. Chemicals & Pharmaceuticals Ltd. Pharmaceutical composition for controlled drug delivery system
EP1536774A1 (en) * 2002-09-04 2005-06-08 Ranbaxy Laboratories Limited Taste masked dosage forms and processes for their preparation
US8691272B2 (en) * 2005-12-30 2014-04-08 Intelgenx Corp. Multilayer tablet
US9622979B2 (en) * 2011-06-29 2017-04-18 Sun Pharmaceutical Industries Limited Multilayered dosage form

Also Published As

Publication number Publication date
GB2518475A (en) 2015-03-25
GB201407847D0 (en) 2014-06-18
WO2015040422A1 (en) 2015-03-26

Similar Documents

Publication Publication Date Title
EP3004067A4 (en) Fungicidal compositions
GB201307577D0 (en) New compounds
GB201309085D0 (en) Compounds
GB201311888D0 (en) Novel compounds
EP2968071A4 (en) Device for oral delivery of therapeutic compounds
EP3019148A4 (en) Compositions containing two phenolic compounds for cosmetic use
HK1212694A1 (en) Tetrahydropyrrolothiazine compounds
GB201317363D0 (en) Novel compounds
GB201304526D0 (en) New compounds
PL2976387T3 (en) Mineral-filled polypropylene composition
GB201301895D0 (en) Pharmaceutical compositions
HK1224312A1 (en) Novel compounds
GB201322602D0 (en) Pharmaceutical compounds
HK1222658A1 (en) Cyanotriazole compounds
GB201311910D0 (en) Novel Compounds
EP2832730A4 (en) Mirabegron-containing pharmaceutical composition
GB201302427D0 (en) Nanoparticle delivery compositions
EP2993213A4 (en) Composition containing trifluoroethylene
EP2889350A4 (en) Tacky-adhesive composition
EP2990038A4 (en) Solid pharmaceutical composition
GB201310542D0 (en) Compounds
EP2981285A4 (en) Novel nanoparticle compositions
EP2990039A4 (en) Solid pharmaceutical composition
GB2520581B (en) Fragrance composition
EP2958994A4 (en) Vaccine composition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)